Jam City, Inc. Launches Disney Magic Match 3D Worldwide
9.10.2025 17:00:00 EEST | Business Wire | Press release
Leading mobile entertainment studio Jam City today announced the worldwide launch of Disney Magic Match 3D, an enchanting new casual game developed in collaboration with Disney and Pixar Games. Now available for download on iOSand Android,Disney Magic Match 3D brings Disney and Pixar’s cherished nostalgia to life through sorting and collecting challenges of 3D pile puzzle play.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251009110858/en/
Leading entertainment studio Jam City launches the casual mobile game Disney Magic Match 3D in collaboration with Disney and Pixar Games. Solve challenging 3D pile puzzles, collect Disney and Pixar items and charming characters, and explore enchanted worlds in this cozy, relaxing game. Disney Magic Match 3D is now available for download in the App Store and Google Play.
InDisney Magic Match 3D, players are invited to restore order to the enchanted Book of Magic, whose magic has gone awry, spilling iconic Disney and Pixar items across the pages. Players must match enchanted objects, organize the whimsical clutter, and rediscover the joy of tidying up to restore order to the Book of Magic—one cozy level at a time.
With its vibrant, tactile art style and charming characters, the game features a calming and comforting soundscape inspired by ASMR and lo-fi content. Disney Magic Match 3D was created by the world-class development team behind the widely popular Disney Emoji Blitz, bringing decades of experience in game development. More than a puzzle game, it is a mindful, relaxing escape that builds on Jam City’s reputation for creating some of the world’s most beloved casual games.
“Disney Magic Match 3D is designed to be a calming, joyful experience,” said Jam City co-founder and CEO Josh Yguado. “Working with Disney, we’ve created a soothing game for players to reconnect and relax with the stories and characters they love, reveling in the nostalgic magic that makes Disney and Pixar so timeless.”
“Disney Magic Match 3D is a charming new entry in the casual puzzle space that is sure to delight Disney and Pixar fans," said Luigi Priore, VP and GM of Disney & Pixar Games. “The team at Jam City has done a great job combining this new expression of our characters and worlds with cozy, compelling gameplay.”
Players can watch the official trailer and download the game today on the App Store and Google Play. To stay up to date on new features and events, follow Disney Magic Match 3D on Instagram, Facebook, YouTube and TikTok.
Disney Magic Match 3D features:
- Delightful Story –Step into the Book of Magic, a living book whose magic has gone awry, spilling Disney and Pixar characters, stories and objects across its pages. Match enchanted items to restore order to the book!
- Charming 3D Puzzles – Collect and organize enchanting 3D puzzles immersed in Disney nostalgia for a soothing escape.
- Disney Classics – Engage with 12+ iconic Disney and Pixar franchises at launch—including Cinderella, Encanto, Moana, Toy Story, Snow White,Aladdin, and Disney Parks—with new additions monthly.
- Iconic Items – Find and collect hundreds of beloved, iconic Disney and Pixar items from the Glass Slipper, to Woody’s Hat, and even Disney Park classics like a turkey leg!
- Magic Moments Card Album Collection Events –Collect themed film still cards that capture scenes and songs such as “Be Our Guest” from Disney’s Beauty and the Beast and “A Whole New World” from Disney’s Aladdin, unlocking adorable new 3D collectible characters.
- Magic Minis – Play through Card Album events to unlock and collect unique and adorable 3D characters. New characters are available each month.
- Enchanted Levels – Discover rare items and story moments that deepen the connection to Disney and Pixar’s most magical tales.
- Immersive Experience – Elegant visuals, high-quality haptics, and rich audio create a warm and polished world of cozy, relaxing gameplay.
About Jam City, Inc.
Jam City is a leading mobile entertainment studio with a proven track record of creating some of the world’s most beloved casual puzzle and story-driven games. As the creative force behind fan-favorite, award-winning titles such as Harry Potter: Hogwarts Mystery, Cookie Jam and Panda Pop, Jam City develops engaging, polished, and dynamic games that become an enduring part of our players’ lives. The company is headquartered in Los Angeles with a global network of studios and talent located in Los Angeles (HQ), Burbank, Cedar Falls, San Diego, San Francisco, and internationally, in Berlin, Buenos Aires, Montevideo, and Toronto. For more information, please visit www.jamcity.com.
@Disney @Disney/Pixar
View source version on businesswire.com: https://www.businesswire.com/news/home/20251009110858/en/
Contacts
Media Contact:
Jam City: Michelle Curran, michelle.curran@jamcity.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom